# Androgens

## Length of Authorizations

365 Days

**All Authorizations**

Must be prescribed in accordance with FDA approved labeling

## Additional Criteria

### Clinical PA

-   Must provide documentation of lab work to support the need for testosterone supplementation

### Non-Preferred

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred dug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage
-   Must have had an inadequate clinical response of at least **90 days** with **all preferred** drugs
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

-   Must provide documentation of patientâ€™s clinical response to treatment and ongoing safety monitoring (i.e., testosterone and hematocrit)

## Formulary

Endocrine Agents: Androgens

### Preferred

| Preferred                   |
| :-------------------------- |
| Androderm PA                |
| Testosterone Gel 1% PA      |
| Testosterone Gel 1% Pump PA |

### Non-Preferred

| Non-Preferred             |
| :------------------------ |
| Jatenzo                   |
| Methyltestosterone        |
| Natesto                   |
| Testopel                  |
| Testosterone Cypionate    |
| Testosterone Gel 1.62%    |
| Testosterone Gel 2%       |
| Testosterone Sol 30mg/ACT |
| Tlando                    |
| Xyosted                   |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=48)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=19)